SoftBank Corp. (SOBKY)

ASLAN Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	69,886	66,118	61,231	54,385	55,324	60,894
Market Cap Growth	7.98%	7.98%	12.59%	-1.70%	-9.15%	0.55%
Enterprise Value	110,493	105,141	99,642	95,037	102,620	104,909
Last Close Price	14.41	13.96	12.88	11.29	10.84	11.79
PE Ratio	20.13	19.04	18.99	13.61	12.98	13.71
PS Ratio	1.60	1.51	1.52	1.22	1.18	1.29
PB Ratio	2.45	2.32	2.35	1.96	2.33	2.45
P/FCF Ratio	16.85	15.94	13.51	13.23	13.26	7.84
P/OCF Ratio	7.65	7.24	7.47	6.26	5.53	5.03
EV/Sales Ratio	2.51	2.41	2.48	2.14	2.19	2.23
EV/EBITDA Ratio	9.69	9.22	9.39	8.31	7.37	9.53
EV/EBIT Ratio	17.32	16.41	17.50	16.71	12.89	11.82
EV/FCF Ratio	26.64	25.35	21.98	23.12	24.59	13.50
Debt / Equity Ratio	1.40	1.40	1.61	1.67	2.08	2.07
Debt / EBITDA Ratio	3.49	3.49	3.94	4.04	3.55	3.79
Debt / FCF Ratio	9.60	9.60	9.22	11.22	11.84	6.63
Asset Turnover	0.41	0.41	0.40	0.43	0.46	0.47
Inventory Turnover	19.53	19.53	20.06	21.63	22.60	24.98
Quick Ratio	0.62	0.62	0.66	0.70	0.69	0.64
Current Ratio	0.71	0.71	0.75	0.78	0.77	0.76
Return on Equity (ROE)	15.98%	15.98%	15.50%	19.91%	20.71%	24.57%
Return on Assets (ROA)	3.79%	3.79%	3.56%	3.45%	4.85%	5.57%
Return on Capital (ROIC)	5.86%	5.86%	5.36%	5.05%	6.97%	8.05%
Return on Capital Employed (ROCE)	10.40%	10.40%	10.20%	9.10%	13.10%	14.20%
Earnings Yield	4.97%	5.31%	5.28%	7.35%	7.70%	7.29%
FCF Yield	5.94%	6.27%	7.40%	7.56%	7.54%	12.76%
Dividend Yield	0.40%	0.41%	0.44%	0.57%	0.65%	0.66%
Payout Ratio	77.71%	77.71%	83.17%	76.32%	77.99%	82.54%
Buyback Yield / Dilution	0.16%	0.16%	-0.19%	0.35%	0.11%	0.94%
Total Shareholder Return	0.56%	0.57%	0.26%	0.92%	0.76%	1.60%

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.